XML 33 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED) - USD ($)
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net Loss $ (1,924,311) $ (388,561)
Adjustments to reconcile net loss to net cash used by operating activities:    
Gain on extinguishment of debt (785,240) 0
Stock based compensation 649,334 0
Operating lease expense (90,946) 0
Loan acquisition costs (480,450) (9,900)
Derivative liability (741,789) 44,684
Amortization of debt discount 404,087 39,414
Depreciation and amortization 116,736 38,271
Changes in operating assets and liabilities:    
Accounts receivable (893,366) 0
Inventory 410,836 0
Unbilled Revenue (563,555) 0
Customer Deposits 1,634,397 0
Contract liability (1,439,504) 0
Accounts payable and accrued expenses (4,362,016) 280,370
Operating lease liabilities 1,398,068 0
Other current liabilities (778,874) 0
Net Cash Used by Operating Activities (7,446,593) 4,278
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of property and equipment (78,662) 0
Business acquisitions, net of cash received (152,683) 0
Deposits (124,000) 0
Investment in patents (191,420) (4,969)
Net Cash Used by Investing Activities (546,765) (4,969)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from sale of common stock from offering 8,000,000 0
Proceeds from convertible notes payable 1,102,700 0
Payments on convertible notes (384,600) 0
Proceeds from notes payable 2,000,000 0
Net Cash Provided by Financing Activities 10,718,100 0
Net Cash Increase (Decrease) 2,724,742 (691)
Effect of exchange rate on cash (160,587) 0
Cash, Beginning of Period 337 1,210
Cash, End of Period 2,564,492 519
Supplementary Cash Flow Information:    
Interest paid in cash 0 0
Taxes paid in cash 0 0
Non-cash finance and investing activities for the quarter ending September 30:    
Issuance of common stock for convertible notes payable and accrued interest 181,560 0
Issuance of common stock for Wildlife Specialists 750 0
Issuance of common stock for Remote Intelligence $ 750 $ 0